Antiviral drug used to treat cats may be effective in treating humans against COVID-19: Research


PTI, Aug 28, 2020, 5:45 PM IST

Image for representation

A drug used to cure a deadly viral disease in cats may be effective as a treatment for humans against the novel coronavirus, according to a study that may lead to the development of new therapeutics to treat COVID-19.

According to the research, published in the journal Nature Communications, the drug is effective at inhibiting viral replication in lab-grown cells infected with the novel coronavirus SARS-CoV-2.

“This drug is very likely to work in humans, so we’re encouraged that it will be an effective antiviral treatment for COVID-19 patients,” said Joanne Lemieux, a professor of biochemistry at the University of Alberta.

The scientists noted that the drug interferes with the virus’s ability to replicate, and may help end the infection.

They said the drug is an inhibitor of some of the body’s protease molecules, which are key to many body functions, and are common targets for drugs to treat “everything from high blood pressure to cancer and HIV.”

According to the scientists, the drug was first studied following the 2002-03 SARS pandemic, following which the protease inhibitor was further developed by veterinary researchers who showed it cures a disease that is fatal in cats.

“We determined the three-dimensional shape of the protease with the drug in the active site pocket, showing the mechanism of inhibition. This will allow us to develop even more effective drugs,” Lemieux said.

The scientists said they plan to test modifications of the drug to make it an even better fit inside the virus.

But, according to Lemieux, the current drug shows enough antiviral action against SARS-CoV-2 to proceed immediately to clinical trials.

“Typically for a drug to go into clinical trials, it has to be confirmed in the lab and then tested in animal models,” Lemieux said.

“Because this drug has already been used to treat cats with coronavirus, and it’s effective with little to no toxicity, it’s already passed those stages and this allows us to move forward,” she added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

100 engineering colleges in Karnataka to be ‘adopted’ by corporates by next year: IT Minister Kharge

Siddaramaiah defends BPL ration card cancellation, says only ineligible beneficiaries affected

China announces new policy measures to protect its exports from Trump’s new tariff threat

Renovated Medical Oncology OPD and Chemotherapy Day Care Centre inaugurated at Kasturba Hospital, Manipal

Karnataka Health Minister justifies revision of user fees in state-run hospitals

Related Articles More

BTS2024: If India can make rocket sensors, it can also make car sensors, says ISRO chief Somanath

World COPD Day: Know your lung function

SpaceX successfully launches ISRO’s 4,700 kg communication satellite from US

As AI and megaplatforms take over, the hyperlinks that built the web may face extinction

Plastic waste could double by 2050, researchers find, suggest policies to address issue

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Siddaramaiah says confident of winning all three bypolls in Karnataka

Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

AIMPLB to hold its annual general sessions in Bengaluru from November 23

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.